Invention Grant
US09073859B2 Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound
有权
4- [2-(2-氟苯氧基甲基)苯基]哌啶化合物的结晶形式
- Patent Title: Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound
- Patent Title (中): 4- [2-(2-氟苯氧基甲基)苯基]哌啶化合物的结晶形式
-
Application No.: US14060846Application Date: 2013-10-23
-
Publication No.: US09073859B2Publication Date: 2015-07-07
- Inventor: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- Applicant: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah
- Main IPC: A61K31/4409
- IPC: A61K31/4409 ; C07D211/22 ; C07D211/32
![Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound](/abs-image/US/2015/07/07/US09073859B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
Public/Granted literature
- US20140045892A1 CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL) PHENYL]PIPERIDINE COMPOUND Public/Granted day:2014-02-13
Information query
IPC分类: